Search Page
Save citations to file
Email citations
Email address has not been verified. Go to
My NCBI account settings
to confirm your email and then refresh this page.
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Consensus guidelines for assessing eligibility of pathogenic DNA variants for antisense oligonucleotide treatments.
Am J Hum Genet. 2025 May 1;112(5):975-983. doi: 10.1016/j.ajhg.2025.02.017. Epub 2025 Mar 25.
Am J Hum Genet. 2025.
PMID: 40139194
Free PMC article.
Review.
Screening rare genetic diagnoses for amenability to bespoke antisense oligonucleotide therapy development: A retrospective cohort study.
Cheerie D, Lauffer MC, Newton L, Amburgey K, Beijer D, Haque B, Kalish BT, Meserve MM, Oh RY, Pan AY, Reuter MS, Szego MJ, Szuto A; N=1 Collaborative; Aartsma-Rus A, Axford MM, Deshwar AR, Dowling JJ, Marshall CR, Ivakine Z, Synofzik M, Yu TW, Costain G.
Cheerie D, et al. Among authors: meserve mm.
Genet Med. 2025 Oct 11;28(1):101597. doi: 10.1016/j.gim.2025.101597. Online ahead of print.
Genet Med. 2025.
PMID: 41090344
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.